You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
江蘇吳中(600200.SH):蘇州製藥廠收到《行政處罰決定書》
格隆匯 12-18 19:31

格隆匯12月18日丨江蘇吳中(600200.SH)公佈,近日,蘇藥廠收到江蘇省藥品監督管理局《行政處罰決定書》。

江蘇省藥品監督管理局認為:根據《中華人民共和國藥品管理法(2015修訂)》、《中華人民共和國藥品管理法(2019修訂)》相關規定,蘇藥廠生產注射用硫酸阿米卡星的行為系涉嫌生產劣藥的行為。根據《中華人民共和國行政處罰法》有關規定,行政處罰如下:1、沒收注射用硫酸阿米卡星56.93萬瓶;2、沒收注射用硫酸阿米卡星違法所得60.25萬元;3、罰款913.77萬元。罰沒款合計為974.02萬元。

問題批次產品事件發生後,公司管理層高度重視,立即啟動召回程序,並停止生產、銷售該藥品。

2019年度,蘇藥廠生產的注射用硫酸阿米卡星(0.2g)銷售收入887.13萬元,佔公司2019年度營業收入0.42%。問題批次產品所涉品種“注射用硫酸阿米卡星”的銷售收入佔公司整體營業收入比重較小,對公司的正常生產經營未造成實質性影響。上述罰沒款將計入公司2020年度當期損益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account